CoChat

Level of Maternal Antibody Required to Protect Neonates against Early‐Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study

Lin, Feng‐Ying C., Philips III, Joseph B., Azimi, Parvin H., Weisman, Leonard E., Clark, Penny, Rhoads, George G., Regan, Joan, Concepcion, Nelydia F., Frasch, Carl E., Troendle, James, Brenner, Ruth A., Gray, Barry M., Bhushan, Reva, Fitzgerald, Geri, Moyer, Patricia, Clemens, John D. · 2001 · The Journal of Infectious Diseases
Cited by 134

The DOI matches its Crossref record.

Abstract

Because of the difficulty of conducting efficacy trials of vaccines against group B streptococcus (GBS), the licensure of these vaccines may have to rely on studies that measure vaccine-induced antibody levels that correlate with protection. This study estimates the level of maternal antibody required to protect neonates against early-onset disease (EOD) caused by GBS type Ia. Levels of maternal serum IgG GBS Ia antibodies, measured by ELISAs in 45 case patients (neonates with EOD caused by GBS Ia) and in 319 control subjects (neonates colonized by GBS Ia but without EOD) born at > or =34 weeks gestation were compared. The probability of developing EOD declined with increasing maternal levels of IgG GBS Ia antibody (P = .03). Neonates whose mothers had levels of IgG GBS Ia antibody > or =5 microg/mL had an 88% lower risk (95% confidence interval, 7%-98%) of developing type-specific EOD, compared with those whose mothers had levels < 0.5 microg/mL. A vaccine that induces IgG GBS Ia antibody levels > or =5 microg/mL in mothers can be predicted to confer a high degree of type-specific immunity to EOD to their infants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/323350

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 134

Metadata

Authors
Lin, F. C., Philips III, J. B., Azimi, P. H., Weisman, L. E., Clark, P., Rhoads, G. G., Regan, J., Concepcion, N. F., Frasch, C. E., Troendle, J., Brenner, R. A., Gray, B. M., Bhushan, R., Fitzgerald, G., Moyer, P., & Clemens, J. D.
Venue
The Journal of Infectious Diseases
Published
2001-10-15
Volume
184
Issue
8
Pages
1022-1028
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2157517505
Cited by
134
References
0
FWCI
6.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Level of Maternal Antibody Required to Protect Neonates against Early‐Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study. https://app.cochat.ai/papers/10.1086/323350
The paper
Lin, F. C., Philips III, J. B., Azimi, P. H., Weisman, L. E., Clark, P., Rhoads, G. G., Regan, J., Concepcion, N. F., Frasch, C. E., Troendle, J., Brenner, R. A., Gray, B. M., Bhushan, R., Fitzgerald, G., Moyer, P., & Clemens, J. D. (2001). Level of Maternal Antibody Required to Protect Neonates against Early‐Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study. The Journal of Infectious Diseases. https://doi.org/10.1086/323350

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.